2025 annual financial data
Cytek Biosciences 2025 Net margin
Direct answer
Net margin was -33.02%.
Operating income was -40,384,000 USD and net income was -66,539,000 USD.
Operating cash flow was -4,686,000 USD.
Get free Cytek Biosciences email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 201,493,000 USD
- Operating income
- -40,384,000 USD
- Net income
- -66,539,000 USD
- Operating cash flow
- -4,686,000 USD